| Ticker | VERA |
|---|---|
| ISIN | US92337R1014 |
| Sector | Tecnología |
| Mercado | NASDAQ |
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clin...
Vera Therapeutics, Inc opera en el sector Healthcare, industria Biotechnology.